Please login to the form below

Not currently logged in
Email:
Password:

Roche launches RPF

Swiss pharmaceutical company, Roche, has launched a new international research grant scheme for scientists involved in collaborative projects between the industry and academic institutions
Swiss pharmaceutical company, Roche, has launched a new international research grant scheme for scientists involved in collaborative projects between the industry and academic institutions.

The scheme will replace the current Roche Research Foundation (RRF), which will cease operating by the end of 2008. It is hoped that the new autonomous foundation will promote young talent and research excellence in Switzerland.

Scientists who are awarded a grant under the recently launched Roche Postdoc Fellowship (RPF) programme will benefit from scientific mentoring from the company and its academic partners. The company aims to award 100 postdoctoral fellowships in various areas of therapeutic research over the next two years, with a long-term view of expanding the RPF into an international scheme.

ìWe believe firmly that in setting up this programme we are making an important contribution to scientific excellence at international level," said Dr Renè Imhof, designated head of the RPF programme.

"Our intention is to channel the positive momentum generated by the RRF into the new, much broader Roche Postdoc Fellowship programme and continue its success there."

Roche plans to unveil an internet site for the scheme during the 4th quarter of 2008 that will include further information about the RPF and an online application system.

20th June 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics